Radiofrequency and Microwave Ablation as Minimally Invasive Approaches for Managing Benign Thyroid Nodule

The management of benign thyroid nodules has evolved significantly with the advent of minimally invasive techniques, offering patients effective alternatives to traditional surgery. Among these, radiofrequency ablation (RFA) and microwave ablation (MWA) have emerged as the leading modalities. RFA, the most widely adopted method, uses high frequency alternating current to induce thermal coagulation. MWA, though less established in thyroid applications, employs electromagnetic waves to generate rapid and intense heat, making it particularly effective for larger or hypervascular nodules. These approaches are particularly advantageous for patients with symptomatic nodules or cosmetic concerns, as they preserve thyroid function while minimizing complications and recovery time. This protocol establishes a standardized approach for RFA and MWA of benign thyroid nodules. The procedure begins with cytological confirmation (Bethesda II) and ultrasound evaluation, followed by local anesthesia and protective hydrodissection with 40-80 mL of 5% dextrose or distilled water to safeguard critical structures. Under real-time ultrasound guidance, the trans-isthmic approach is employed for needle placement. Ablation is performed at 30-40 W (RFA) or 35-50 W (MWA) using the moving-shot technique. Complete nodule devascularization is confirmed by contrast-enhanced ultrasound (CEUS) during post-ablation assessment, with immediate supplementary ablation being performed if residual enhancement is identified. Clinical and sonographic follow-up is conducted at 1, 3, 6, and 12 months to assess volume reduction ratio, symptom relief, and cosmetic outcomes. The protocol also details the patient selection criteria, technical nuances for cystic/solid nodules, and management of intraoperative complications. This comprehensive guide aims to optimize the reproducibility, safety, and efficacy of thermal ablation for benign thyroid nodules, serving as a practical reference for clinicians adopting these minimally invasive techniques.

Authors

Institutions

Publication Details

Journal
Journal of Visualized Experiments
Published
2025-08-12
DOI
https://doi.org/10.3791/68640
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Radiofrequency and Microwave Ablation as Minimally Invasive Approaches for Managing Benign Thyroid Nodule

Yunjun Wang, Peixuan Sun, Yuyang Tong, Cai Chang
Journal of Visualized Experiments
Thyroid Cancer Diagnosis and Treatment
article

Radiofrequency and Microwave Ablation as Minimally Invasive Approaches for Managing Benign Thyroid Nodule

Yunjun Wang, Peixuan Sun, Yuyang Tong, Cai Chang
article en

Abstract

The management of benign thyroid nodules has evolved significantly with the advent of minimally invasive techniques, offering patients effective alternatives to traditional surgery. Among these, radiofrequency ablation (RFA) and microwave ablation (MWA) have emerged as the leading modalities. RFA, the most widely adopted method, uses high frequency alternating current to induce thermal coagulation. MWA, though less established in thyroid applications, employs electromagnetic waves to generate rapid and intense heat, making it particularly effective for larger or hypervascular nodules. These approaches are particularly advantageous for patients with symptomatic nodules or cosmetic concerns, as they preserve thyroid function while minimizing complications and recovery time. This protocol establishes a standardized approach for RFA and MWA of benign thyroid nodules. The procedure begins with cytological confirmation (Bethesda II) and ultrasound evaluation, followed by local anesthesia and protective hydrodissection with 40-80 mL of 5% dextrose or distilled water to safeguard critical structures. Under real-time ultrasound guidance, the trans-isthmic approach is employed for needle placement. Ablation is performed at 30-40 W (RFA) or 35-50 W (MWA) using the moving-shot technique. Complete nodule devascularization is confirmed by contrast-enhanced ultrasound (CEUS) during post-ablation assessment, with immediate supplementary ablation being performed if residual enhancement is identified. Clinical and sonographic follow-up is conducted at 1, 3, 6, and 12 months to assess volume reduction ratio, symptom relief, and cosmetic outcomes. The protocol also details the patient selection criteria, technical nuances for cystic/solid nodules, and management of intraoperative complications. This comprehensive guide aims to optimize the reproducibility, safety, and efficacy of thermal ablation for benign thyroid nodules, serving as a practical reference for clinicians adopting these minimally invasive techniques.

Journal of Visualized Experiments(222)
Shanghai Children's Medical Center (CN), Fudan University Shanghai Cancer Center (CN)
Zero hunger
Openalex Percentile: Top 71%
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.